1. Rasmussen B.K., Lipton B.: Epidemiology of Tension-Type Headache. [W:] The Headache pod red. Olesen J., Tfelt-Hansen P., Welch MK. Lippincott Williams & Wilkins Philadelphia, 2000, 545–550. 2. Schwartz B.S. et al.: Epidemiology of tension-type headache. JAMA, 1998, 279:381-383. 3. Srikiatkhachorn A., Phanthumchinda K.: Prevalence and clinical features of chronic daily cheadache in headache clinic. Headache, 1997, 37:277-280. 4. Schwartz B.S. et al.: Epidemiology of tension type headache. JAMA, 1998, 279:381-383. 5. Ishaq Abu-Arafeh: Chronic tension-type headache in childern and adolescents. Cephalalgia, 2001, 21:830-836. 6. Gladstein J., Holden E.W.: Chronic daily headache in childern and adolescents: 2 year prospective study. Headache, 1996, 36:349-351. 7. Schoenen J. et al.: EMG activity in pericranial muscles during postural variation and mental activity in healthy volunteers and patients with chronic tension type headache. Headache, 1991, 31:321-324. 8. Schoenen J., Bendtsen L.: Neurophysiology of tension type headache. [W:] The Headache pod red. Olesen J., Tfelt-Hansen P., Welch MK. Lippincott Williams & Wilkins Philadelphia, 2000, 573-588. 9. Moskowitz M.A., Macfarlane R.: Neurovascular and molecular mechanisms in migraine headaches. Cerebrovascular Brain Met. Rev., 1993, 5:159-177. 10. Williamson D.J., Hargreaves R.J.: Neurogenic inflammation in the context of migraine. Microsc. Res. Tech., 2001 May 1; 53(3):167-78 11. Hamon M., Bourgoin S.: Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses. Pathol. Biol., 2000 Sep; 48(7):619-29. 12. Hargreaves R.J., Shepheard S.L.: Pathopsysiology of migraine – new insights. Can. J. Neurol. Sci., 1999 Nov; 26 Suppl 3:12-9. 13. Edvinsson L. et al.: Nerve supply and receptor mechanisms in intra- and extracerebral blood vesels. [W:] Olesen J, Edvinsson L. Basic mechanisms of headache. New York: Elsevier 1988,129-144. 14. Feuerstein G. et al.: Clinical perspectives of calcitonin gene related peptide pharmacology. Can. J. Physiol. Pharmacol. 1995 Jul; 73(7):1070-4. 15. Ashina M. et al.: Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology, 2000, 55:1335-1339. 16. Meller S.T., Gebhart G.F.: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain, 1993, 52:127-287. 17. Ashina M. et al.: Effect of inhibition of nitric oxide synthase on chronic tension type headache: a randomized crossover trial. Lancet, 1999, 353:287-289. 18. Andersen A.R. et al.: Regional cerebral blood flow in chronic tension type headache. [W:] Olesen J. et al.: Migraine and other headaches: the vascular mechanisms. New York: Raven Press, 1991, 319-321. 19. Rasmussen B.K.: Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to the lifestyle. Pain, 1993, 53:65-72. 20. Olesen J., Schoenen J.: Tension-type headache, cluster headache, and miscellaneous headache. Synthesis. [W:] Olesen J., Tfelt-Hansen P., Welch KMA. The Headaches. New York, NY: Raven Press. 1993, 493-496. 21. Bendtesn L. et al.: Decreased pain detection and tolerance thresholds in chronic tension type headache. Arch. Neurol., 1996, 53:373-376. 22. Bendtsen L.et al.: Serotonin metabolism in chronic tension-type headache. Cephalalgia, 1997, 17:843-848. 23. Shimomura T., Takahashi K.: Alteration of platent serotonin in patients with chronic tension-type headache during cold perssor test. Headache, 1990, 30:581-583. 24. Eide P.K., Hole K.: The role of 5-hydroksytryptamine (5HT) receptor subtypes and plasticity in the 5HT systems in the regulation of nociceptive sensivity. Cephalalgia, 1993, 13:75-85. 25. Rainero L.et al.: Decreased sensivity of 5HT1D receptors in chronic tension-type headache. Headache, 2002, 42(8):709-714. 26. Puca F. et al.: Psychiatric comorbility and psychosocial stress in patients with tension-type headache from headache centers in Italy. Cephalalgia, 1999, 19:159-164. 27. Newman L.C. et al.: Daily headache in population sample. Results from the American Migraine Study. Headache, 1994, 34:294. 28. Iversen H.K. et al.: Clinical characteristics of migraine and tension type headache in relation to old and new diagnostic criteria. Headache, 1990, 30:514-519. 29. Prusiński A.: Polekowe bóle głowy „z odbicia”. Migrena, 1999, 2:11-12. 30. Report of the Quality Standards Subcommittee of the American Academy of neurology. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Neurology, 1994, 44:1353-1354. 31. Bryson H.M., Wilde M.I.: Amitryptyline; a reviev of its pharmacological properties and thetapeutic use in chronic pain states. Drug Aging, 1996, 8:459-476. 32. Prusiński A.: Bóle głowy. PZWL, Warszawa, 1999. 33. Jung A.C. et al.: The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J. Gen. Inter. Med., 1997, 12:384-389. 34. Fogelholm R., Murros K.: Tizanidine in chronic tension-type headache: a placebo controlled double blind cross-over study. Headache, 1992, 32:509-513. 35. Murros K. et al.: Modified-release Formulation of Tizanidyne in chronic tension – type headache. Headache, 2000, 40:633-637. 36. Smuts J.A. et al.: Prophylactic treatment of chronic tension type headache using botulinum toxin type A. Eur. J. Neurology, 1999, 6 (suppl 4):99-102. 37. Rollnik JD. et al.: Treatment of tension type headache with botulinum toxin type A. Headache, 2000, 40:300-305. 38. Robbins L.: Botulinum Toxin A for Refractory Chronic Daily Headache. Cephalalgia, 2001, 21(4):480. 39. Brin M.F.: Botulin toxin: chemistry, pharmacology,toxicity and immunology. Muscle Nerve, 1997, supl 6:146-168.